Elekta AB (EKTA B):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Elekta AB (EKTA B) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7017
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:78
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Elekta AB (Elekta) is a medical technology company that offers image guided and stereotactic clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. Its major products include Gamma knife and Extend system; stereotactic system; fully integrated stereotactic radiation therapy system; system for volumetric arc modulated therapy (VMAT); image guided radiation therapy (IGRT) systems; advanced digital treatment systems; treatment planning systems; electronic brachy therapy for skin cancer; and automated remote after loading platform. It also offers oncology information systems for radiation oncology and medical oncology, treatment planning software, cancer registry and soft tissue visualization software, among others. The company operates in North America, Europe, the Middle East, Africa and Asia-Pacific. Elekta is headquartered in Stockholm, Sweden.

Elekta AB (EKTA B) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Elekta AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Elekta AB, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Elekta AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Elekta AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Elekta AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Elekta AB, Medical Equipment, Deal Details 12
Asset Purchase 12
Elekta to Acquire Assets of Asesores Electronics Especializados 12
Partnerships 13
Elekta to Enter into Agreement with RTsafe 13
Elekta Enters into Research Agreement with Memorial Sloan Kettering Cancer 14
Elekta Partners with Palabra Apps 15
Elekta to Enter into Agreement with IBA 16
Elekta Enters into Agreement with BrainLAB 17
Elekta Expands Distribution Agreement with Brainlab 18
Elekta Enters into Distribution Agreement with Kobold Medical 19
Elekta Enters into Distribution Agreement with Toshiba Medical Systems for Linear Accelerator 20
Varian Medical Systems Enters Into Integration Agreement With Elekta For VMAT Treatments 21
Philips Enter Into Co-Development Agreement With Elekta And University Medical Center Utrecht 22
Elekta Enters Into Collaboration With Brainlab For Radiosurgery Software 23
Elekta And BrainLAB Enter Into Technology Integration Agreement 24
Elekta Enters Into Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital For Cancer Solutions 25
Equity Offering 26
Elekta Announces Private Placement Of Common Stock 26
Debt Offering 27
Elekta Announces Public Offering of Bonds Due 2020 for USD35.3 Million 27
Elekta Announces Public Offering of Floating Rate Bonds Due 2020 for USD82.4 Million 28
Elekta Completes Private Placement Of Convertible Bonds For US$284 Million 29
Asset Transactions 30
York Instruments Acquires MEG Business from Elekta 30
Genesis Care Acquires Portfolio Business from Elekta 31
Elekta to Acquire Assets of Asesores Electronics Especializados 32
Equra Health To Acquire 15 Radiation Therapy Systems And Allied Equipment From Elekta 33
Banner MD Anderson Cancer Center Acquires Multiple Elekta Cancer Management Systems 34
Advanced Radiation Therapy Acquires AccuBoost Assets From Elekta 35
Acquisition 36
Elekta Acquires RTA, Medical Technologies Distributor 36
Elekta Acquires Mesi Medikal, Provider of Radiation Oncology Solutions 37
Elekta Acquires Radon, Linear Accelerator Service Company 38
Elekta AB – Key Competitors 39
Elekta AB – Key Employees 40
Elekta AB – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 44
Strategy And Business Planning 44
Sep 05, 2018: Elekta celebrates inauguration of new global radiotherapy innovation center 44
Jan 31, 2018: Elekta taps IBM Watson Health to bring AI to comprehensive oncology field 45
Jun 22, 2017: Equicare Health and Elekta announce Vendor Interoperability Program partnership 46
Feb 08, 2017: Elekta Partners With ESTRO Cancer Foundation to Increase Radiation Therapy Awareness and Access in Europe 47
Financial Announcements 48
Aug 30, 2018: Elekta: Interim report May-July 2018/19 48
Jun 01, 2018: Elekta: Year-end report May-April 2017/18 49
Mar 02, 2018: Elekta: Interim Report May-January 2017/18 50
Nov 30, 2017: Elekta Announces its Interim report May-October 2017/18 52
Aug 23, 2017: Elekta: Interim Report May-July 2017/18 54
Jun 01, 2017: Elekta: Year-end report May-April 2016/17 55
Mar 01, 2017: Elekta Announces Interim Report May-January 2016/17 57
Corporate Communications 59
Aug 23, 2017: Elekta: Ioannis Panagiotelis appointed as Chief Marketing and Sales Officer 59
Jul 14, 2017: Steven Wort appointed as Elekta’s Chief Operating Officer 60
Jun 01, 2017: Peter Gaccione joins Elekta’s Executive Management as head of North America 61
May 10, 2017: Elekta appoints Gustaf Salford as Chief Financial Officer 62
Legal and Regulatory 63
Apr 03, 2017: Varian Medical Systems and Elekta Settle Patent Litigation 63
Government and Public Interest 64
Feb 03, 2017: Leaders In Cancer Radiotherapy Recognize World Cancer Day Through Elekta Brachytherapy Equipment Donation 64
Product News 65
Sep 18, 2017: Elekta to highlight MOSAIQ Oncology Analytics, a game-changing solution for managing the oncology treatment pathway, at ASTRO Annual Meeting 65
May 26, 2017: Elekta Radiosurgery Solutions Highlighted at International Stereotactic Radiosurgery Society Congress 67
May 02, 2017: Elekta to Showcase the Latest in Stereotactic Solutions at ESTRO 36 68
Other Significant Developments 69
Jul 25, 2018: Elekta Implements PTC’s ThingWorx on Microsoft Azure for Next Generation Remote Service 69
Jul 13, 2018: Elekta to donate advanced radiation therapy machine to Jordan’s Al Bashir Hospital 70
Dec 12, 2017: Elekta and Stockholm County Council agree on constructive way forward 71
Nov 29, 2017: UK’s National Health Service signs GBP 22 million agreement for Elekta cancer treatment systems 72
Nov 21, 2017: 21st Century Oncology chooses Elekta for replacement of radiation therapy devices 73
Oct 02, 2017: Elekta and The Alliance for Cancer Care partner to bring leading-edge radiation therapy and radiosurgery solutions to patients 74
Aug 03, 2017: C-RAD to supply advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna 75
Jun 26, 2017: Elekta Chooses Brainlab to Distribute Stereotactic Neurosurgical Solutions Within Selected Markets in Europe 76
Jun 20, 2017: Alliance Cancer Care to Upgrade Cancer Care in Southeastern U.S. with Elekta Solutions 77
Appendix 78
Methodology 78
About GlobalData 78
Contact Us 78
Disclaimer 78

List of Tables
Elekta AB, Medical Equipment, Key Facts, 2018 2
Elekta AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Elekta AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Elekta AB, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Elekta AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Elekta AB, Deals By Market, 2012 to YTD 2018 9
Elekta AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Elekta to Acquire Assets of Asesores Electronics Especializados 12
Elekta to Enter into Agreement with RTsafe 13
Elekta Enters into Research Agreement with Memorial Sloan Kettering Cancer 14
Elekta Partners with Palabra Apps 15
Elekta to Enter into Agreement with IBA 16
Elekta Enters into Agreement with BrainLAB 17
Elekta Expands Distribution Agreement with Brainlab 18
Elekta Enters into Distribution Agreement with Kobold Medical 19
Elekta Enters into Distribution Agreement with Toshiba Medical Systems for Linear Accelerator 20
Varian Medical Systems Enters Into Integration Agreement With Elekta For VMAT Treatments 21
Philips Enter Into Co-Development Agreement With Elekta And University Medical Center Utrecht 22
Elekta Enters Into Collaboration With Brainlab For Radiosurgery Software 23
Elekta And BrainLAB Enter Into Technology Integration Agreement 24
Elekta Enters Into Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital For Cancer Solutions 25
Elekta Announces Private Placement Of Common Stock 26
Elekta Announces Public Offering of Bonds Due 2020 for USD35.3 Million 27
Elekta Announces Public Offering of Floating Rate Bonds Due 2020 for USD82.4 Million 28
Elekta Completes Private Placement Of Convertible Bonds For US$284 Million 29
York Instruments Acquires MEG Business from Elekta 30
Genesis Care Acquires Portfolio Business from Elekta 31
Elekta to Acquire Assets of Asesores Electronics Especializados 32
Equra Health To Acquire 15 Radiation Therapy Systems And Allied Equipment From Elekta 33
Banner MD Anderson Cancer Center Acquires Multiple Elekta Cancer Management Systems 34
Advanced Radiation Therapy Acquires AccuBoost Assets From Elekta 35
Elekta Acquires RTA, Medical Technologies Distributor 36
Elekta Acquires Mesi Medikal, Provider of Radiation Oncology Solutions 37
Elekta Acquires Radon, Linear Accelerator Service Company 38
Elekta AB, Key Competitors 39
Elekta AB, Key Employees 40
Elekta AB, Other Locations 41
Elekta AB, Subsidiaries 41

List of Figures
Elekta AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Elekta AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Elekta AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Elekta AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Elekta AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Elekta AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Elekta AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Elekta AB, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Elekta AB (EKTA B):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Groupama Assurances Mutuelles:企業の戦略的SWOT分析
    Groupama Assurances Mutuelles - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Woori Bank:戦略・SWOT・企業財務分析
    Woori Bank - Strategy, SWOT and Corporate Finance Report Summary Woori Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Fujirebio Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent con …
  • Nativis Inc-医療機器分野:企業M&A・提携分析
    Summary Nativis Inc (Nativis) is a clinical stage bio-electronics company. Its portfolio of pipeline candidates which are under development for various therapeutic areas include recurrent glioblastoma, brain metastisis, pain, rheumatoid arthritis, lung cancer and melanoma. The company’s lead product …
  • National Electric Power Co:企業の戦略的SWOT分析
    National Electric Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • TranSystems Corporation:企業の戦略・SWOT・財務情報
    TranSystems Corporation - Strategy, SWOT and Corporate Finance Report Summary TranSystems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Elizabeth Arden, Inc. (RDEN):企業の財務・戦略的SWOT分析
    Elizabeth Arden, Inc. (RDEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • General Mills Inc:企業のM&A・事業提携・投資動向
    General Mills Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's General Mills Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • EchoStar Corporation:企業の戦略・SWOT・財務情報
    EchoStar Corporation - Strategy, SWOT and Corporate Finance Report Summary EchoStar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PixarBio Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary PixarBio Corp (PixarBio), formerly BMP Holdings Inc is a biotechnology company that discovers and develops novel neurological drug delivery systems for postsurgical pain, acute pain, and chronic pain. The company offers research and commercial development of targeted drug delivery systems, b …
  • RCL Foods Ltd. (RCL):企業の財務・戦略的SWOT分析
    RCL Foods Ltd. (RCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ConAgra Brands Inc:企業のM&A・事業提携・投資動向
    ConAgra Brands Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ConAgra Brands Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Sumitomo Mitsui Trust Holdings Inc:企業の戦略・SWOT・財務分析
    Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Crew Energy Inc (CR):企業の財務・戦略的SWOT分析
    Summary Crew Energy Inc (Crew Energy) is an exploration and production company that offers our long-term production and development of crude oil and natural gas resources. The company offers exploration, development, strategic acquisitions, operations, management, and production programs. It operate …
  • Informatica Corporation:企業のM&A・事業提携・投資動向
    Informatica Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Informatica Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Butler National Corporation:企業の戦略・SWOT・財務情報
    Butler National Corporation - Strategy, SWOT and Corporate Finance Report Summary Butler National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Collegium Pharmaceutical Inc (COLL):企業の財務・戦略的SWOT分析
    Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • S2Medical AB:製品パイプライン分析
    Summary S2Medical AB (S2Medical) is a medical technology company that designs, develops and markets wound dressings and products to treat burns and chronic ulcers. The company’s product portfolio consists of wound dressing patches; blood stilling synthetic epithelium dressing to control capillary bl …
  • Phillips 66 (PSX):企業の財務・戦略的SWOT分析
    Phillips 66 (PSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • British Broadcasting Corporation:戦略・SWOT・企業財務分析
    British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report Summary British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆